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Brominated compounds such as 7-bromo-L-tryptophan (7-Br-Trp) occur in Nature. Many
synthetic and natural brominated compounds have applications in the agriculture, food,
and pharmaceutical industries, for example, the 20S-proteasome inhibitor TMC-95A that
may be derived from 7-Br-Trp. Mild halogenation by cross-linked enzyme aggregates
containing FAD-dependent halogenase, NADH-dependent flavin reductase, and alcohol
dehydrogenase as well as by fermentation with recombinant Corynebacterium
glutamicum expressing the genes for the FAD-dependent halogenase RebH and
the NADH-dependent flavin reductase RebF from Lechevalieria aerocolonigenes have
recently been developed as green alternatives to more hazardous chemical routes. In
this study, the fermentative production of 7-Br-Trp was established. The fermentative
process employs an L-tryptophan producing C. glutamicum strain expressing rebH and
rebF from L. aerocolonigenes for halogenation and is based on glucose, ammonium and
sodium bromide. C. glutamicum tolerated high sodium bromide concentrations, but its
growth rate was reduced to half-maximal at 0.09 g L−1 7-bromo-L-tryptophan. This may
be, at least in part, due to inhibition of anthranilate phosphoribosyltransferase by 7-Br-Trp
since anthranilate phosphoribosyltransferase activity in crude extracts was half-maximal
at about 0.03 g L−1 7-Br-Trp. Fermentative production of 7-Br-Trp by recombinant C.
glutamicum was scaled up to a working volume of 2 L and operated in batch and
fed-batch mode. The titers were increased from batch fermentation in CGXII minimal
medium with 0.3 g L−1 7-Br-Trp to fed-batch fermentation in HSG complex medium,
where up to 1.2 g L−1 7-Br-Trp were obtained. The product isolated from the culture
broth was characterized by NMR and LC-MS and shown to be 7-Br-Trp.
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INTRODUCTION
Brominated tryptophan is typically not found in free form inNature, but as a biosynthetic precursor
in complex structures that for example occur in sponges and lower marine invertebrates (Bittner
et al., 2007). The brominated molecules often exhibit pharmaceutical and biological activities. For
example, TMC-95A which derives from 7-bromo-L-tryptophan (7-Br-Trp) is biologically active
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against the chymotrypsin-like, trypsin-like, and peptidyl-
glutamyl-peptide-hydrolyzing activities of the 20S proteasome
of eukaryotic cells (Koguchi et al., 2000). Protease inhibitors
may be promising candidates for tumor and inflammation
therapies (Adams, 2004; Vergnolle, 2016). Free unprotected
halotryptophans including 7-Br-Trp and 7-chloro-L-tryptophan
(7-Cl-Trp) can serve as substrates for Pd-catalyzed cross-
coupling reactions (Willemse et al., 2017) for example in the
Suzuki-Miyaura cross-coupling in order to attach an aryl,
heteroaryl, or alkenyl substituent to the indole ring (Roy et al.,
2008). For this reaction, 7-Br-Trp is preferred because it is
more reactive than 7-Cl-Trp (Corr et al., 2017). In addition,
7-Br-Trp can also be used in other transition metal-catalyzed
cross couplings such as the Mizoroki-Heck reaction (Gruß et al.,
2019) giving fluorescent styryl-tryptophans or the Sonogashira
cross-coupling reaction (Sonogashira, 2002) to generate
compounds such as the new-to-nature bromo-cystargamide
or to selectively modify bromo-tryptophan residues as a
component of a tripeptide (Corr et al., 2017). 7-Cl-Trp is not
useful for the Sonogashira cross coupling reaction since it is too
unreactive (Corr et al., 2017). Furthermore, 7-Br-Trp can easily
be converted to 7-bromoindole, which may give rise to many
indole derivates including the MOM-protected 7-bromoisatin,
which is the precursor of the antimitotic agent diazonamide A
(Nicolaou et al., 2002; Wang et al., 2007; Bartoli et al., 2014).
Halogenation of L-tryptophan (Trp) involves two enzymes
of the reb operon of Lechevalieria aerocolonigenes, the FAD-
dependent halogenase RebH and the NADH-dependent flavin
reductase RebF required for NADH-dependent redox cofactor
regeneration (Nishizawa et al., 2005). The halogenase RebH from
L. aerocolonigenes chlorinates Trp to 7-Cl-Trp, the precursor of
rebeccamycin. While this enzyme also accepts bromide, it prefers
chloride over bromide (Yeh et al., 2005). Purified cross-linked
enzyme aggregates comprising RebH, RebF, and an alcohol
dehydrogenase to regenerate NADH by oxidation of isopropanol
have successfully been applied to the enzymatic bromination
of Trp at the gram-scale (Frese and Sewald, 2015; Schnepel
and Sewald, 2017). Fermentative production of 7-Cl-Trp has
recently been established using recombinant Corynebacterium
glutamicum (Veldmann et al., 2019).
Fermentation processes with C. glutamicum that serves as
a work horse for the biotechnological production of different
amino acids are scalable and in the case of L-lysine and L-
glutamate applied at the million-ton scale (Wendisch, 2019).
Fermentative processes unlike chemical synthesis routes do not
require environmentally hazardous compounds (e.g., elemental
chlorine or bromine) or protecting/activating groups because of
the high stereo-and regioselectivities of the enzymes involved.
Biotransformations using purified enzymes may suffer from
low stability and low activity (e.g., of halogenases), especially
under non-native reaction conditions in the presence of high
substrate concentrations (Latham et al., 2017). Fermentative
processes start from sugars and the biocatalyst is (re)generated
during growth. Fermentative processes are excellent for synthesis
if export of the product out of the cell is efficient and
neither substrates nor products nor intermediates inhibit
cellular metabolism.
C. glutamicum typically shows higher tolerance to many
substances including organic acids, furan, and phenolic
inhibitors present in lignocellulose hydrolysates (Sakai et al.,
2007). Adaptive laboratory evolution led to increased tolerance
to methanol (Leßmeier and Wendisch, 2015) or lignocellulose
derived inhibitors (Wang et al., 2018). Thus, C. glutamicum was
engineered for production of carboxylic acids such as pyruvate
(Wieschalka et al., 2012) and succinate (Litsanov et al., 2012),
oxoacids such as 2-ketoisovalerate (Krause et al., 2010) and
2-ketoisocaproate (Bückle-Vallant et al., 2014), alcohols such as
ethanol (Inui et al., 2004a), isobutanol (Blombach et al., 2011),
and n-propanol (Siebert and Wendisch, 2015), polymers such as
polyhydroxyalkanoate (Ma et al., 2018). As industrial amino acid
producer C. glutamicum is ideal for fermentative production of
various other nitrogenous compounds such as the cyclic amino
acid pipecolic acid (Pérez-García et al., 2016), the ω-amino
acids γ-aminobutyrate (Kim et al., 2013; Jorge et al., 2016;
Pérez-García et al., 2016) and 5-aminovalerate (Rohles et al.,
2016; Jorge et al., 2017), the diamines putrescine (Schneider
and Wendisch, 2010) and cadaverine (Tateno et al., 2009; Kim
et al., 2018) and alkylated and hydroxylated amino acids such as
N-methylalanine (Mindt et al., 2018) and 5-hydroxy-isoleucine
(Wendisch, 2019). Noteworthy, several excellent C. glutamicum
producer strains have been developed for production of muconic
acid (Becker et al., 2018), phenylpropanoids (Kallscheuer and
Marienhagen, 2018), para-hydroxybenzoic acid (Purwanto et al.,
2018), and protocatechuate (Wendisch et al., 2016; Lee and
Wendisch, 2017).
Accordingly, the Trp overproducing strain Tp679 (Purwanto
et al., 2018) served as excellent base strain for halogenation of Trp
(Veldmann et al., 2019). In C. glutamicum wildtype mutant trpE
encoding a feedback resistant anthranilate synthase component
1 from C. glutamicum and trpD encoding an anthranilate
phosphoribosyltransferase from E. coli were overexpressed to
channel the flux from chorismate to Trp. The chorismate mutase
csm was deleted to prevent the formation of the by-products
L-phenylalanine and L-tyrosine. The precursor supply was
optimized with the overexpression of aroG encoding a feedback
resistant 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase
from E. coli (Figure 1). The production of 7-Cl-Trp had already
been established with the Trp producing C. glutamicum strain
overexpressing rebH and rebF. The strain produced about 0.1 g
L−1 of 7-Cl-Trp (Veldmann et al., 2019). However, bromination
of Trp in vivo has not yet been described as basis of a fermentative
process leading 7-Br-Trp or other brominated tryptophans.
Here, we describe the production of 7-Br-Trp with the above
described Trp overproducing C. glutamicum strain expressing
rebH and rebF in media with low chloride, but high bromide
concentrations. The process was upscaled in bioreactors with a
volume of 2 L and 7-Br-Trp was isolated and characterized by
NMR and MS.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. Escherichia coli DH5α (Hanahan, 1983) was used for
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FIGURE 1 | Schematic representation of metabolic engineered C. glutamicum overproducing Trp and 7-Br-Trp. Genes names are shown next to reaction represented
by the arrows. Dashed arrows show several reactions. Heterologously expressed genes are marked by blue boxes, endogenously overexpressed genes are marked
by ↑ and deleted genes are showed by red crosses. FBR, feedback resistant.
TABLE 1 | Strains and plasmids used in this work.
Strains and plasmids Description Source
Strains
WT C. glutamicum wild type,
ATCC 13032
ATCC
Tp679 (pCES208-trpD) 1csm
1trpL::PilvCM1-trpE
FBR
1vdh::PilvCM1-aroG
FBR
with pCES208-trpD
Purwanto et al., 2018
HalT2 Tp679
(pCES208-trpD)(pEKEx3-
optimRBS-rebH-rebF )
Veldmann et al., 2019
Plasmids
(pCES208-trpD) KanR, pCES208
overexpressing trpD from E.
coli with PilvCM1
Purwanto et al., 2018
(pEKEx3-optimRBS-
rebH-rebF )
SpecR, pEKEx3
overexpressing rebH, rebF
from L. aerocolonigenes
with optimized RBS for rebH
Veldmann et al., 2019
cloning the plasmid constructs. E. coli and C. glutamicum were
regularly grown in lysogeny broth medium (LB medium) in
500mL baﬄed flasks at 120 rpm at 37◦C or 30◦C, respectively.
For growth and production experiments C. glutamicum was
inoculated in CGXII minimal medium (Eggeling and Bott, 2005)
in 500 or 100mL baﬄed flasks (filling volume 10%) to an optical
density (OD600) of 1 and incubated at 120 rpm. Growth was
monitored by measuring the optical density at 600 nm using
a V-1200 spectrophotometer (VWR, Radnor, PA, USA). For
toxicity test C. glutamicum was grown in the BioLector R© (M2P
Labs) in CGXII medium supplemented with the substance to
be tested. To produce 7-Br-Trp, CGXII minimal medium or
HSG rich medium (40.0 g L−1 glucose, 13.5 g L−1 soy peptone,
7 g L−1 yeast extract, 0.01 g L−1 NaCl, 2.3 g L−1 K2HPO4, 1.5 g
L−1 KH2PO4, 0.249 g L−1 MgSO4 × H2O) were used and
supplemented with 50mM NaBr. Strains derived from Tp679
were supplemented additionally with 1.37mM L-tyrosine and
1.5mM L-phenylalanine in minimal medium. If necessary, the
growth medium was supplemented with kanamycin (25 µg
mL−1) and/or spectinomycin (100 µg mL−1). Isopropyl-β-D-1-
thiogalactopyranoside (IPTG) (1mM) was added to induce the
gene expression from the vector pEKEx3 (Stansen et al., 2005).
Determination of the Specific Activity of
the Anthranilate
Phosphoribosyltransferase TrpD
The anthranilate phosphoribosyltransferase overproducing
strain Tp679 (pCES208-trpD) was inoculated from an overnight
culture and was cultivated for 24 h in LB medium at 30◦C
with 120 rpm before cells were centrifuged for 10min at 4◦C
and 4,000 rpm and stored at −20◦C. After resuspension in
100mM Tricine buffer (pH 7.0), the cells were sonicated for
9min at 55% amplitude and 0.5 cycles on ice in the UP200S
Ultrasonic Processor from Hielscher Ultrasound Technology.
The supernatant obtained after centrifugation (60min, 4◦C,
16,400 rpm) was used as crude extract for the enzyme assay.
The activity was assayed fluorometrically by monitoring the
decrease of anthranilate (Ant) at room temperature. The
reaction mixture with a final volume of 1mL contained 100mM
Tricine buffer (pH 7.0), 15µM Ant, 0.3mM PRPP, 10mM
MgCl2, and the crude extract and was filled in a quartz glass
cuvette (Hellma Analytics, High Precision cell, Light Path
10 × 4mm). Ant was detected by fluorescence at 325 nm
excitation and 400 nm emission wavelength with the Shimadzu
Spectrofluorophotometer RF-5301PC. Protein concentrations
were determined by the Bradford method (Bradford, 1976) with
bovine serum albumin as reference. Means and errors from
triplicates were calculated.
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Bioreactor Cultures Operated in Batch and
Fed-Batch Mode
A 3.7 L KLF Bioengineering AG stirred tank reactor was used
for the production of 7-Br-Trp. The fermentation was performed
at pH 7.0, 30◦C, and an aeration rate of 2 norm liter (NL)
min−1. pH was controlled by automatic addition of phosphoric
acid [10% (w/w)] and ammonium hydroxide [25% (w/w)].
Struktol R©J647 (Schill and Seilenbacher, Boeblingen, Germany)
serves as antifoam agent and was also added automatically.
Samples were taken automatically every 2 h and cooled to 4◦C
until analysis.
For the batch fermentations the relative dissolved oxygen
saturation (rDOS) of 15, 30, and 60%, respectively, was controlled
by enhancing the stirrer speed gradually in steps of 2%. Two
liter CGXII without MOPS but with 50mM NaBr, 1.37mM L-
tyrosine, 1.5mM L-phenylalanine, and 1mM IPTG (added at
timepoint 0 h) was used as culture medium.
For the fed-batch fermentation the initial volume was 2 L
and a constant overpressure of 0.2 bar was adjusted. Due to the
new findings (see Figure 6), the culture medium was changed to
HSG rich medium supplemented with 50mM NaBr and 1mM
IPTG (added at timepoint 0 h). The feeding medium contained
150 g L−1 ammonium sulfate, 400 g L−1 glucose, 5.14 g L−1 NaBr,
0.25 g L−1 L-tyrosine, and 0.25 g L−1 L-phenylalanine. Automatic
control of the stirrer speed kept the rDOS at 30%. The feeding
started automatically when rDOS exceeds 60% and stops when
rDOS felt again under the set-point. Here, a pH of 7.0 was
established and controlled by automatic addition of phosphoric
acid [10% (w/w)] and potassium hydroxide (4M). Instead of
using ammonium hydroxide as alkali to avoid nitrogen limitation
in batch cultures, potassium hydroxide was used in the fed-batch
fermentation, since the HSG complex medium is nitrogen rich
and, hence, a nitrogen limitation was excluded.
The titer and yield were calculated to the initial volume.
Analytical Procedures
For the quantification of the extracellular Trp, 7-Br-Trp
and anthranilate (Ant) a high-pressure liquid chromatography
(HPLC) system was used (1200 series, Agilent Technologies
Deutschland GmbH, Böblingen, Germany). The supernatants
of the cell culture were collected by centrifugation (14,680
rpm, 20min, RT) and further used for analysis. For detection
of Ant, Trp, and the derivatives, samples were reacted
with ortho-phthaldialdehyde (OPA) (Schneider and Wendisch,
2010). The amino acid separation was performed by a
precolumn (LiChrospher 100 RP18 EC-5µ (40 × 4mm), CS-
Chromatographie Service GmbH, Langerwehe, Germany) and
a column (Li-Chrospher 100 RP18 EC-5µ (125 × 4mm),
CS Chromatographie Service GmbH). The detection was
carried out with a fluorescence detector (FLD G1321 A, 1200
series, Agilent Technologies) with the excitation and emission
wavelengths of 230 and 450 nm, respectively. The quantification
of carbohydrates and organic acids was done using a column
for organic acids (300 × 8mm, 10mm particle size, 25 Å pore
diameter, CS Chromatographie Service GmbH) and detected by
a refractive index detector (RID G1362A, 1200 series, Agilent
Technologies) and a diode array detector (DAD G1315B, 1200
series, Agilent Technologies) (Schneider et al., 2011).
Analytical RP-HPLC and RP-HPLC-MS
Analytical HPLC was performed on a Shimadzu NexeraXR 20A
System with autosampler, degasser, column oven, diode array
detector, and a Phenomex Luna C18 column (2.9µm, 50 ×
2.1mm) with a gradient (in 5.5min from 5% B to 95% B, 0.5min
95% B and back to 5% B in 3min, total run time 9min) at a flow
rate of 650µL/min and column oven temperature of 40◦C. HPLC
solvent A consists of 99.9% water and 0.1% TFA, solvent B of
99.9% acetonitrile and 0.1% TFA.
Analytical LC-MS was performed on an Agilent 6220 TOF-
MSwith a Dual ESI-source, 1200HPLC systemwith autosampler,
degasser, binary pump, column oven, diode array detector, and
a Hypersil Gold C18 column (1.9µm, 50 × 2.1mm) with a
gradient (in 11min from 0% B to 98% B, back to 0% B in 0.5min,
total run time 15min) at a flow rate of 300 µL/min and column
oven temperature of 40◦C. HPLC solvent A consisted of 94.9%
water, 5% acetonitrile, and 0.1% formic acid, solvent B of 5%
FIGURE 2 | Response of C. glutamicum wild type to externally added NaBr (A) and 7-Br-Trp (B). To determine the K i for NaBr and 7-Br-Trp C. glutamicum wildtype
was grown in CGXII minimal medium with 40 g L−1 glucose and different concentration of the substances to be tested. A linear regression was done to determine the
half maximal specific growth rate with the substances to be tested. (A) NaBr concentrations between 0 and 500mM were tested with C. glutamicum. (B) 7-Br-Trp
concentrations between 0 and 0.5mM were tested.
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water, 94.9% acetonitrile and 0.1% formic acid. ESI mass spectra
were recorded after sample injection via 1200 HPLC system in
extended dynamic range mode equipped with a Dual-ESI source,
operating with a spray voltage of 2.5 kV.
NMR Spectroscopy
NMR spectra were recorded on a Bruker Avance III 500 HD (1H:
500MHz, 13C: 126MHz, 19F: 471MHz). Chemical shifts δ [ppm]
are reported relative to residual solvent signal (DMSO-d6, 1H:
2.50 ppm, 13C: 39.5 ppm). 2D spectra (COSY, HMQC, HMBC)
spectra were used for signal assignment.
High-Resolution MS
ESI mass spectra were recorded using an Agilent 6220 time-
of-flight mass spectrometer (Agilent Technologies, Santa Clara,
CA, USA) in extended dynamic range mode equipped with
a Dual-ESI source, operating with a spray voltage of 2.5 kV.
Nitrogen served both as the nebulizer gas and the dry gas.
Nitrogen was generated by a nitrogen generator NGM 11.
Samples are introduced with a 1200 HPLC system consisting
of an autosampler, degasser, binary pump, column oven, and
diode array detector (Agilent Technologies, Santa Clara, CA,
USA) using a C18 Hypersil Gold column (length: 50mm,
diameter: 2.1mm, particle size: 1.9µm) with a short isocratic
flow (60% B for 5min) at a flow rate of 250 µL/min and
column oven temperature of 40◦C. HPLC solvent A consisted
of 94.9% water, 5% acetonitrile, and 0.1% formic acid, solvent B
of 5% water, 94.9% acetonitrile, and 0.1% formic acid. The mass
axis was externally calibrated with ESI-L Tuning Mix (Agilent
Technologies, Santa Clara, CA, USA) as calibration standard. The
mass spectra were recorded in both profile and centroid mode
with the MassHunter Workstation Acquisition B.04.00 software
(Agilent Technologies, Santa Clara, CA, USA). MassHunter
Qualitative Analysis B.07.00 software (Agilent Technologies,
Santa Clara, CA, USA) was used for processing and averaging of
several single spectra.
Reversed-Phase Column Chromatography
(GP1)
Automated column chromatography was performed on a Büchi
Reveleris X2 with a binary pump and ELSD Detector using a
Biotage SnapUltra C18 columnwith a gradient (4min at 5%B, up
to 25% B in 14min, in 1min up to 100% B for 2min and flushing
with 80% B for 5min, total run time 27min) at a flow rate of
30 mL/min. Solvent A consisted of 99.9% water and 0.1% TFA,
solvent B of 99.9% acetonitrile and 0.1% TFA.
Isolation and Purification of
7-Bromo-L-tryptophan From HSG Rich
Medium
7-Br-Trp was isolated from 30mLHSG richmedium (3× 10mL)
(see chapter growth conditions) by an automated reversed phase
column chromatography. The crude medium was centrifuged
(10,000 rpm, 4◦C, 30min) and filtrated over a short plug of celite.
The crude filtrate was loaded on a 12 g C18-column and purified
according to GP1. The TFA salt of 7-Br-Trp was isolated as a
colorless solid (14.3mg, 36 µmol). RP-column chromatography:
tR = 11.5min; Anal. RP-HPLC: tR = 3.3min; LC-MS: tR =
5.1min; 1HNMR (500MHz, DMSO-d6) δ [ppm]= 11.28 (d, 3J=
2.7Hz, 1H, indole-NH), 8.16 (brs, 3H, NH+3 ), 7.58 (d,
3J= 7.9Hz,
1H, C4-H), 7.32 (d, 3J = 7.5Hz, 1H, C6-H), 7.30 (d, 3J = 2.7Hz,
1H, C2-H), 6.97 (dd, 3J = 7.8Hz, 3J = 7.8Hz, 1H, C5-H), 4.15
(dd, 3J = 7.1Hz, 3J = 6.2Hz, 1H, Cα-H), 3.27 (dd, 2J = 15.0Hz,
3J = 5.7Hz, 1H, Cβ-H), 3.22 (dd, 2J = 14.8Hz, 3J = 6.9Hz,
1H, Cβ-H); low res. MS (ESI): found [m/z] = 265.9 [M(79Br)-
NH2]+, 267.9 [M(81Br)-NH2]+, 283.0 [M(79Br)+H]+, 285.0
[M(81Br)+H]+; calcd. [m/z] = 265.9 [M(79Br)-NH2]+, 267.9
[M(81Br)-NH2]+, 283.0 [M(79Br)+H]+, 285.0 [M(81Br)+H]+.
RESULTS
Production of 7-Bromo-L-tryptophan in
Flasks Culture
Fermentative processes are ideal if substrates, intermediates, and
products do not inhibit growth and production. The effect of
the substrate NaBr and the product 7-Br-Trp on growth of C.
glutamicum was assessed when various concentrations of these
compounds were added upon inoculation of C. glutamicum wild
type to CGXII minimal medium with 40 g L−1 glucose. NaBr
concentrations (0–500mM) had a negligible effect on growth
and it was estimated by extrapolation that the growth rate would
be reduced to 50% at about 1.2M NaBr (Figure 2A). Therefore,
the use of NaBr as a substrate was presumed to be possible.
By contrast, already low concentrations of the target product
7-Br-Trp inhibited growth in the BioLector R© (M2P Labs). The
half maximal specific growth rate of C. glutamicum was reached
already at a concentration of about 0.32mM or 0.091 g L−1
FIGURE 3 | Specific activities of anthranilate phosphoribosyltransferase TrpD
in the presence or absence of either 7-Br-Trp or 7-Cl-Trp. Crude extracts of C.
glutamicum Tp679 (pCES208-trpD) grown in LB rich media were assayed for
TrpD activity in the presence of different concentrations of either 7-Br-Trp or
7-Cl-Trp. Means and standard deviations of triplicates are shown.
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7-Br-Trp (Figure 2B). This inhibition is threefold lower than
previously observedwith 7-Cl-Trp (K i of about 0.1mMor 0.024 g
L−1 (Veldmann et al., 2019). We hypothesize that the difference
is due to the hydration shell of chlorine substituents being smaller
than that of a bromo substituent. Accordingly, we speculate that
due to its smaller size 7-Cl-Trp can enter catalytic active centers
and/or allosteric sites of enzymes easier than 7-Br-Trp and, thus,
inhibitory effects are expected to be more pronounced. This
may explain why the inhibitory effect of 7-Cl-Trp exceeds that
of 7-Br-Trp.
Since it is known that halogenated Ant competitively inhibits
Ant converting anthranilate phosphoribosyltransferase TrpD
(Lesic et al., 2007), it was tested whether 7-Br-Trp inhibits
anthranilate phosphoribosyltransferase in crude extracts of
C. glutamicum Tp679 (pCES208-trpD). This strain possesses
endogenous trpD on its chromosome and expresses E. coli
trpD from a plasmid. Crude extracts of C. glutamicum Tp679
(pCES208-trpD) grown in LB rich medium were assayed for
TrpD activity in the presence of different concentrations of
either 7-Br-Trp or 7-Cl-Trp (Figure 3). The specific activity
of anthranilate phosphoribosyltransferase was reduced to about
one third by either 0.15mM 7-Br-Trp or by 0.05mM 7-Cl-Trp
(Figure 3). Thus, inhibition by 7-Cl-Trp was more pronounced
than inhibition by 7-Br-Trp, which showed a K i value of
about 0.03 g L−1. At least in part, the growth inhibition by 7-
Br-Trp (Figure 2B) may be due to inhibition of anthranilate
phosphoribosyltransferase by 7-Br-Trp (Figure 3). Since 7-Br-
Trp exerts a lower inhibitory effect than 7-Cl-Trp and since
the latter could be produced to a titer of 0.108 g L−1, i.e., five
times as high as K i (Veldmann et al., 2019), it is expected that
C. glutamicum likely produces 7-Br-Trp only to relatively low
concentrations as well.
For the fermentative production of 7-Br-Trp, the C.
glutamicum strain HalT2 was used. This strain was derived from
the Trp overproducing strain Tp679 (pCES208-trpD), which
overexpresses additionally genes encoding FAD-dependent
halogenase RebH and NADH-dependent flavin reductase RebF
from the expression vector pEKEx3 (Veldmann et al., 2019).
In our previous study, we tried to optimize RebF and RebH
gene expression. On the one hand, a more active promoter
helped increase RebH and RebF activities, on the other hand,
production could be improved as consequence of optimizing the
ribosome binding site [and thus, translation initiation efficiency;
(Veldmann et al., 2019)]. Bioinformatics analysis revealed that
the codon usage of RebH fits to the codon usage of C. glutamicum
and hence was not further optimized. For RebF the codon
usage fits to C. glutamicum except one triplet. The ribosome
binding site was not optimized for RebF. HalT2 was inoculated
in CGXII minimal medium with 40 g L−1 glucose and 50mM
NaBr in 500mL baﬄed flasks (50mL culture) to an OD600 of
1. At inoculation, 1mM IPTG was added. The culture showed
a specific growth rate 0.12 ± 0.01 h−1. After 72 h 0.25 ± 0.01 g
L−1 7-Br-Trp, 0.81 ± 0.02 g L−1 Trp and 1.69 ± 0.03 g L−1 Ant
were measured (Figure 4). When the same strain was inoculated
in 500mL without baﬄes the specific growth rate was 0.11 ±
0.01 h−1 and the production of 7-Br-Trp increased by 38% to a
titer of 0.34 ± 0.02 g L−1. Production of Trp was decreased by
34% to 0.54 ± 0.02 g L−1, but production of Ant increased to
FIGURE 4 | Production of 7-Br-Trp, Trp, and Ant by C. glutamicum HalT2 under different shake flask conditions. HalT2 was grown in CGXII with 40 g L−1 glucose
after 72 h were measured the titers of 7-Br-Trp, Trp, and Ant. The filling volume was 10% of the flask volume. Means and standard deviations of three replicate
cultivations are shown.
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1.91 ± 0.03 g L−1. Using 100mL flasks with 10mL culture was
beneficial for production of 7-Br-Trp by C. glutamicum HalT2
as in baﬄed flasks 0.48 ± 0.03 g L−1 7-Br-Trp were produced
after 72 h and 0.81 ± 0.01 g L−1 Trp and 2.82 ± 0.06 g L−1 Ant
accumulated. In 100mL flasks without baﬄes 0.49 ± 0.02 g L−1
7-Br-Trp were produced after 72 h and 0.96 ± 0.03 g L−1 Trp
and 3.45 ± 0.13 g L−1 Ant accumulated (Figure 4). With the
assumption that the oxygen supply is lower in the 100ml than in
the 500ml flasks, the production was increased with less oxygen
supply. The specific growth rate was lower in 100mL flasks with
baﬄes (0.09 ± 0.01 h−1 as compared to 0.13 ± 0.01 h−1). These
results were unexpected since oxygen supply in 500mL baﬄed
flasks is considered higher than in 100mL unbaﬄed flasks we
expected higher 7-Br-Trp in 500ml baﬄed flasks. Halogenase
RebH requires FADH2 as cofactor, L-Trp, molecular oxygen and
a halide salt as substrates. RebH regioselectively chlorinates or
brominates L-Trp at the 7-position. FADH2 is regenerated by
RebF, which reduces FAD to FADH2 in an NADH-dependent
manner. NADH is provided by cellular metabolism (oxidation
of glucose). RebH and RebF derive from the host organism
Lechevalieria aerocolonigenes which has a growth optimum at
28◦C (Parte, 2012), which fits well with the optimal growth
temperature of C. glutamicum of 30◦C. Nonetheless, the highest
7-Br-Trp titer observed (about 0.49 g L−1; Figure 4) exceeded the
K i value (about 0.09 g L−1; Figure 2B) about five-fold.
Batch Production of 7-Bromo-L-tryptophan
in a Bioreactor
To scale up the fermentation process and to test the influence
of pH control, optimal stirring and controlled oxygen supply,
strain HalT2 was cultivated in a 3.7 L baﬄed bioreactor with
a working volume of 2 L with three different rDOSs (rDOS =
15, 30, and 60%). Whereas, the maximal specific growth rate
was comparable and in a range between 0.07 and 0.08 h−1, C.
glutamicum HalT2 grew to a higher biomass concentration at
rDOS of 15% (OD600 of 27; Figure 5C) than with rDOS at either
30 or 60% (OD600 of 11 and 12, respectively; Figures 5A,B).
Glucose was utilized completely (with the exception of 3.6 g
L−1 glucose remaining in the rDOS 60% bioreactor condition).
Lactate accumulated transiently peaking at 32 h, 28 and 16 h
with maximal concentrations of 3.8, 3.8, and 0.5 g L−1 lactate
for the bioreactors operated at 15, 30, and 60%, respectively
(Figure 5). The byproducts Trp and Ant accumulated to higher
concentrations than 7-Br-Trp. Maximal 7-Br-Trp titers increased
slightly with decreasing rDOS, i.e., 0.26, 0.26, and 0.30 g L−1
7-Br-Trp for the bioreactors operated at 15, 30, and 60%,
respectively (Figure 5). The corresponding yields on glucose
were 6.6, 6.6, and 7.5mg g−1. The yields on biomass differed
to a larger extent since higher biomass concentrations were
observed at low rDOS. At 15% rDOS, for example, an OD600
21 (corresponding to 7.4 gCDW L−1) and a 7-Br-Trp titer of
0.26 g L−1 were observed at 56 h, which is equivalent to a 7-Br-
Trp yield on biomass of 36mg (gCDW)−1. At 30% rDOS, the
7-Br-Trp yield on biomass was almost two-fold higher [74mg
(gCDW)−1] and it was almost three-fold higher at 60% rDOS
[95mg (gCDW)−1]. This may indicate that less cells are required
FIGURE 5 | Batch fermentation of 7-Br-Trp by C. glutamicum HalT2 with three
different rDOS. The data given include the glucose consumption [blue triangle],
the OD600 [red squares], the production of 7-Br-Trp [green circles], Trp [gray
circles], Ant [black circles], and Lac [light purple circles]. The initial culture
volume was 2 L. (A) Batch fermentation with a rDOS set-point of 60%.
(B) Batch fermentation with a rDOS set-point of 30%. (C) Batch fermentation
with a rDOS set-point of 15%.
for 7-Br-Trp production at high rDOS and/or that growth
proceeds to higher biomass concentrations at low rDOS.
Fed-Batch Production of
7-Bromo-L-tryptophan in a Bioreactor
Stirred tank bioreactor cultivations operated in batch mode
yielded lower titers (0.26–0.30 g L−1; Figure 5) than shake flask
cultivation (up to about 0.49 g L−1; Figure 4). Under both
conditions CGXII glucose minimal medium was used. Since
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FIGURE 6 | Production of 7-Br-Trp by C. glutamicum HalT2 in different media.
HalT2 was grown in CGXII minimal medium and HSG rich medium with 40 g
L−1 glucose. The strain was cultivated in 100mL flasks with 10% filling
volume. After 24 h were determined the production of 7-Br-Trp, Trp, and Ant.
Means and standard deviations of three replicate cultivations are shown.
fermentations are often performed in media containing complex
sources such as yeast extract and/or protein hydrolysates,
production of 7-Br-Trp by C. glutamicum HalT2 was compared
in 100mL baﬄed flasks with either CGXII glucose minimal
medium or HSG rich medium containing yeast extract and soy
peptone. Growth in the HSG rich medium was faster (a specific
growth rate of 0.39 ± 0.02 h−1 as compared to 0.19 ± 0.01 h−1
in CGXII minimal medium). Within 24 h 0.36± 0.04 g L−1 7-Br-
Trp were produced in HSG rich medium, but only 0.10 ± 0.01 g
L−1 7-Br-Trp in the minimal medium (Figure 6). Moreover, the
7-Br-Trp yield on biomass in HSG rich medium [39 ± 5mg
g(CDW)−1] was higher than in CGXII minimal medium [6 ±
1mg g(CDW)−1]. Notably, neither Trp nor Ant accumulated as
byproducts in HSG rich medium, whereas 0.26 ± 0.01 g L−1 Trp
and 1.88 ± 0.05 g L−1 Ant were produced in CGXII minimal
medium (Figure 6).
The product formed by C. glutamicum HalT2 in 30 mL HSG
rich medium (3 × 10 mL) was isolated and purified in a single
step by an automated reversed phase column chromatography.
In total 14.3mg (36 µmol) of 7-Br-Trp as a TFA salt were
isolated. The product was identified as 7-Br-Trp by NMR studies.
The purity (>95%) was verified by both NMR (Figure 7A) and
LC-MS (Figure 7B) experiments.
Taken together, HSG rich medium was chosen for fed-batch
fermentation because the production occurred faster and the
precursors Trp and Ant did not accumulate as byproducts and
the specific growth rate in rich medium was two-fold higher
than in CGXII medium as mentioned above (0.39 h−1 for HSG
medium vs. 0.19 h−1 for CGXII medium). In Figure 6, the
concentrations of Trp, Ant, and 7-Br-Trp after 24 h of cultivation
in shake flasks are given. Most likely, in contrast to CGXII
medium product formation was finished at this time point using
rich medium. This was also confirmed by Figure 5, because
7-Br-Trp formation was not finished after 24 h of cultivation,
irrespective of whether rDOS level was used. At 30% rDOS,
the highest 7-Br-Trp yield on biomass of 74mg (gCDW)−1
was reached as mentioned above. Therefore, the same set point
was used for fed-batch fermentation. C. glutamicum HalT2 was
used for the fed-batch fermentation to inoculate 2 L HSG rich
medium containing 40 g L−1 glucose to an initial OD600 of 1.8
(Figure 8). The maximal specific growth rate was 0.32 h−1. A
total feed of 975mL was added in the whole process. Four major
phases of the fed-batch fermentation could be distinguished. In
the first (batch) phase C. glutamicum HalT2 grew to an OD600
of 37.3 within 18 h. Lactate accumulated transiently peaking at
7.0 g L−1 after 10 h. At 18 h, titers of 0.19 g L−1 7-Br-Trp and
0.1 g L−1 Trp were observed. In the next phase (until 30 h when
exponential feeding started), 7-Br-Trp was produced to a titer of
0.30 g L−1 with a yield on biomass of 0.7mg (gCDW)−1 and a
volumetric productivity of 10mg L−1 h−1. Neither Trp nor Ant
accumulated during this phase. The third phase is characterized
by an exponential increase of the feed volume (at 50 h about
293mL feed had been added and theOD600 reached 62), while the
7-Br-Trp concentration increased linearly to 0.66 g L−1. During
this phase the volumetric productivity was 18mg g−1 h−1 and
the specific productivity was 1mg gCDW−1 h−1. While Trp
accumulated to a titer of 0.17 g L−1, Ant was not produced in
the third phase. In the last phase that started at 50 h, the residual
feed (682mL) was added until 55 h. The 7-Br-Trp and Trp titers
increased in parallel to 1.2 g L−1 and about 0.25 g L−1. Only
in this last phase, Ant accumulated with Ant titers fluctuating
around 0.5 g L−1 from 57 h to 72 h (Figure 8).
DISCUSSION
Heterologous expression of the genes rebH for FAD-dependent
halogenase and rebF for NADH-dependent flavin reductase from
the reb cluster of L. aerocolonigenes to enable regioselective
chlorination of Trp at the 7 position (Nishizawa et al., 2005) in a
Trp overproducing C. glutamicum strain (Purwanto et al., 2018)
provided the basis for the development of fermentative processes
for chlorination (Veldmann et al., 2019) and bromination of
Trp (this study). Production of 7-Br-Trp by the engineered
C. glutamicum strain was possible in glucose minimal media
supplemented with sodium bromide.
C. glutamicum belongs to the group of bacteria that require
chloride for growth at high (sodium) salt concentrations since
growth was inhibited in the presence of high concentrations
of sodium sulfate and sodium gluconate, but not of sodium
chloride (Roeßler et al., 2003). It was postulated that chloride
may enhance excretion of cytotoxic sodium ions by salt-induced
Na+/H+ antiporters and/or simultaneous export of these anions
via the ClC-type sodium channels as observed for E. coli (Iyer
et al., 2002). The finding reported here that C. glutamicum can
withstand high sodium bromide concentrations (K i of about
1.2M; Figure 2A) indicates that bromide may substitute for
chloride to sustain growth of C. glutamicum at high sodium
salt concentrations.
The engineered C. glutamicum strain produced 7-Br-Trp
to higher titers (1.2 g L−1, Figure 8) than 7-Cl-Trp [0.1 g
L−1; (Veldmann et al., 2019)]. This was surprising since pure
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FIGURE 7 | Analysis of 7-Br-Trp isolated from HSG medium by (A) 1H NMR (500 MHz, 298K, DMSO-d6) and by (B) RP-HPLC-MS analysis. The ionization was
performed with a Dual-ESI with a voltage of 2.5 kV leading to an expected deamination during the ionization process. The characteristic isotopic pattern of a single
brominated species is clearly observable.
RebH prefers chlorination (kcat of 1.4 min−1) over bromination
(kcat of 0.4 min−1) (Yeh et al., 2005). Unlike in enzyme
catalysis with pure RebH (Yeh et al., 2005; Payne et al.,
2013), chloride could not be completely replaced by bromide
since chloride is required for growth of C. glutamicum (s.
above). However, at a low chloride concentration in the growth
medium a high bromide salt supply (277-fold excess) allowed
for bromination by the engineered C. glutamicum strain in vivo.
The purified product of this fermentative process was shown
to be 7-Br-Trp without detectable contamination by 7-Cl-Trp
(Figure 7). Brominated natural products and intermediates are
found predominantly in marine environments as ocean water
contains a relatively high bromide ion concentration (Gribble,
1996). Moreover, halogenases which prefer bromination are
more abundant in marine habitats, those preferring chlorination
are encountered more often in terrestrial habitats (Van Peè,
2001). Thus, future process improvement may make use of
halogenases preferring bromination over chlorination such as
BrvH from Brevundimonas BAL3 (Neubauer et al., 2018) or three
halogenases from Xanthomonas campestris pv. campestris strain
B10046 (Ismail et al., 2019).
FAD-dependent halogenases require molecular oxygen (Bitto
et al., 2008). In the reaction catalyzed by RebH, FADH2 binds to
the FAD binding pocket of the RebH and reacts with molecular
oxygen to flavin hydroperoxide (Andorfer et al., 2016). Flavin
peroxide in turn oxidizes the halide anion (X−, X = Cl, Br)
to hypohalous acid (HOX), which is channeled to the active
tryptophan binding pocket. The role of the conserved lysine
residue K79 in giving a haloamine intermediate (Yeh et al., 2007)
is still under debate (Flecks et al., 2008). The hypohalous acid
effects the regioselective electrophilic aromatic substitution of
Trp resulting in halogenation at the C7 position (Andorfer et al.,
2016). Thus, the supply of molecular oxygen to RebH within the
C. glutamicum cell may be a bottleneck for halogenation of Trp.
Since, of course, C. glutamicum requires oxygen for respiration,
the response to increased molecular oxygen supply during
growth-coupled fermentative production of 7-Br-Trp may be
complex. Production of 7-Br-Trp was found to be higher under
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FIGURE 8 | Fed-batch fermentation of 7-Br-Trp by C. glutamicum HalT2. The data given include rDOS [%] [light gray], the feed [blue], OD600 [red squares], 7-Br-Trp
[green circles], Trp [gray circles], Ant [black circles], and Lac [light purple circles]. The initial volume was 2 L and 975mL feed was added. The titer was calculated to
the initial volume.
low oxygen supply in shake flask (although these are relatively ill-
defined) or comparable under controlled conditions in bioreactor
fermentations with rDOS of 15, 30, and 60% (Figures 4, 5).
For different microorganisms the Monod constants for oxygen
are in a range between 3.0 · 10−4 mg L−1 and 0.1mg L−1
(Longmuir, 1954) Therefore, cell growth was not notably affected
by oxygen supply even at a rDOS level of 15%. Surprisingly,
biomass formation was declined with increasing rDOS set points
as shown by the courses of OD600 and glucose in Figure 5. While
glucose was depleted after 35 h for rDOS of 15% and 48 h for
rDOS of 30%, respectively, nearly 4 g L−1 glucose remained at the
end of cultivation (73 h) at a rDOS level of 60% also indicating
a reduced biomass formation. However, halogenation by RebH-
RebF requires molecular oxygen. Obviously, a better oxygen
supply improves RebH-RebF activity, which counteracts biomass
formation (see also max. OD600 mit tiefer gesetzten 600 values
as given in line 719–722). This conclusion is supported by lower
specific growth rates during stirred tank reactor cultivation (line
719) in contrast to shake flask cultivation (line 649–653, 694),
despite a poorer oxygen input in the latter case. In addition,
halogenation by RebH-RebF requires both molecular oxygen
and NADH at the same time. This is difficult to achieve in fast
growing cells as NADH is oxidized by the respiratory chain using
molecular oxygen to generate a trans-membrane pH gradient and
subsequently ATP. Moreover, if the oxygen supply is too high,
the flavin-hydroperoxide formed upon reaction of FADH2 with
molecular oxygen is hydrolyzed to yield H2O2. This is commonly
observed for flavin-dependent enzymes like monooxygenases
and halogenases (“oxygen dilemma”; Ismail et al., 2019). Thus,
all reactions in C. glutamicum requiring FADH2 [e.g., p-
hydroxybenzoate hydroxylase (Kwon et al., 2007) or flavin-
dependent thymidylate synthase; (Kan et al., 2010)] or containing
this flavin bound to the enzyme [e.g., membrane-associated
malate dehydrogenase (acceptor) (EC 1.1.99.16); (Molenaar et al.,
1998)] may be compromised at high oxygen levels in the presence
of flavin reductase RebF. Thus, an aeration protocol ensuring
optimal supply of oxygen for growth on the one hand and
for RebH catalyzed bromination on the other hand remains to
be developed.
Another optimization step for the fermentative production of
7-Br-Trp, would be the reduction of by-products, like L-lactate.
C. glutamicum produces L-lactate from pyruvate via the NAD-
dependent L-lactate dehydrogenase (encoded by ldhA) (Inui
et al., 2004b) and is able to utilize the L-lactate as carbon source
via the lactate dehydrogenase (encoded by lldD) (Stansen et al.,
2005). Transient L-lactate accumulation (formed by LdhA and
subsequently utilize by LldD) is often observed when glucose
uptake is higher than oxygen uptake. Once the glucose uptake
rate ceases, L-lactate is re-utilized. Transcription of ldhA is
regulated by transcriptional regulator SugR (Engels et al., 2008;
Toyoda et al., 2009). Under oxygen limitation glucose uptake
exceeds oxygen uptake and L-lactate is produced by LdhA to
regenerate NAD+ (Engels et al., 2008). Accordingly, transient L-
lactate was more pronounced with low (rDOS of 15%, 30%, and
fed-batch) as compared to high oxygen supply (rDOS of 60%).
We have discussed these facts along with a strategy to avoid
transient lactate formation, i.e., by deletion of ldhA as has been
shown before (Inui et al., 2004b).
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Inhibition by halogenated Trp appeared to be the major
bottleneck to achieve high product titers. Growth as well as
anthranilate phosphoribosyltransferase activity in crude extracts
from C. glutamicum Tp679 (pCES208-trpD) were inhibited
by 7-Br-Trp and 7-Cl-Trp (Figure 3 and Veldmann et al.,
2019). When comparing growth and 7-Br-Trp production in
CGXII and HSG media, the latter of which is a complex
medium and contains about 0.5mM Trp (data not shown),
the specific growth rate in rich medium was two-fold higher
than in CGXII medium (0.39 h−1 for HSG medium vs. 0.19
h−1 for CGXII medium, s. results section). Thus, addition of
Trp may alleviate the growth inhibition as consequence of
TrpD inhibition.
Previously, O’Gara and Dunican (1995) have shown that
purified anthranilate phosphoribosyltransferase TrpD from C.
glutamicum is inhibited by Trp (K i of 0.83mM) and by 5-
methyl-L-tryptophan (K i of 0.32mM). In this study, anthranilate
phosphoribosyltransferase activity in crude extracts was shown
to be inhibited by 7-Br-Trp (K i of about 0.1mM) and by 7-
Cl-Trp (K i of about 0.06mM). It should be noted that besides
endogenous trpD on the C. glutamicum chromosome E. coli trpD
was expressed from a plasmid. TrpD from E. coli is insensitive
to Trp in the absence of E. coli TrpE (Ito and Yanofsky, 1969).
Feedback resistant TrpD has been isolated from C. glutamicum,
which was isolated from a tyrosine and phenylalanine double
auxotrophic strain due to its resistance to analogs of Trp,
tyrosine, phenylalanine, and 5-methyl-L-tryptophan. Feedback
resistant TrpD from this C. glutamicum strain was shown
to confer resistance to 5-methyl-L-tryptophan and 6-fluoro-L-
tryptophan on E. coli (Herry and Dunican, 1993). Resistance to
Trp derivatives with modifications at the 7 position of Trp such
as 7-Br-Trp or 7-Cl-Trp has not been determined, thus, it cannot
be inferred that the feedback resistant TrpD from C. glutamicum
ATCC 21850 would alleviate the inhibition of C. glutamicum
growth and/or TrpD activity by 7-Br-Trp and 7-Cl-Trp. Likely,
other TrpD variants either from C. glutamicum or from E. coli
have to be isolated after mutation and screening or by rational
enzyme engineering. Alternatively, process intensification may
involve fermentation strategies including in situ product
removal (ISPR) to maintain sub-threshold concentrations of
7-Br-Trp as has been shown for L-phenylalanine separation
and concentration by reactive-extraction with liquid-liquid
centrifuges in a fed-batch fermentation process with recombinant
E. coli (Rüffer et al., 2004).
Halogenated amino acids such as 7-Br-Trp are relevant for
peptide synthesis, since they can be converted further by Pd-
catalyzed cross coupling and nucleophilic substitution reactions
(Diederich and Stang, 2008). Various halogenated forms of
tryptophan and its derivatives may have potential in the synthesis
of serotonin and melatonin agonists or antagonists (Frese et al.,
2014). As shown here, based on the insight from enzyme
catalysis using pure RebH, crude RebH preparations or CLEAs
containing RebH, a fermentative process based on RebH was
developed and adjusted to yield either 7-Cl-Trp or 7-Br-Trp by
C. glutamicum in vivo. Since halogenases such as RebH, PrnA,
or BrvH differ in their substrate spectra and regioselectivities,
the fermentative approach holds the potential to be extended
for various halogenation processes starting from glucose and
halide salts in vivo provided that the halogenated products do not
interfere with vital cellular functions and can be exported out of
the cell efficiently.
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